​

Intuitive Surgical (ISRG) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ISRG Stock Forecast

Intuitive Surgical stock forecast is as follows: an average price target of $550.67 (represents a 5.00% upside from ISRG’s last price of $524.43) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.

ISRG Price Target

The average price target for Intuitive Surgical (ISRG) is $550.67 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $650.00 to $466.00. This represents a potential 5.00% upside from ISRG's last price of $524.43.

ISRG Analyst Ratings

Buy

According to 16 Wall Street analysts, Intuitive Surgical's rating consensus is 'Buy'. The analyst rating breakdown for ISRG stock is 0 'Strong Buy' (0.00%), 12 'Buy' (75.00%), 4 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Intuitive Surgical Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Patrick WoodMorgan Stanley$650.00$541.9319.94%23.94%
Oct 18, 2024David RomanGoldman Sachs$604.00$517.9716.61%15.17%
Oct 18, 2024Shagun SinghRBC Capital$555.00$473.7317.16%5.83%
Oct 18, 2024Adam MaederPiper Sandler$538.00$473.7313.57%2.59%
Oct 18, 2024Anthony PetroneMizuho Securities$550.00$473.7316.10%4.88%
Oct 18, 2024Rick WiseStifel Nicolaus$525.00$473.7310.82%0.11%
Oct 18, 2024Richard NewitterTruist Financial$570.00$473.7320.32%8.69%
Oct 18, 2024Vijay KumarEvercore ISI$490.00$473.733.43%-6.57%
Oct 18, 2024Ryan ZimmermanBTIG$535.00$473.7312.93%2.02%
Oct 15, 2024David RescottRobert W. Baird$565.00$487.6115.87%7.74%
Oct 15, 2024Larry BiegelsenWells Fargo$466.00$487.61-4.43%-11.14%
Oct 14, 2024Ryan ZimmermanBTIG$518.00$484.786.85%-1.23%
Oct 08, 2024Shagun SinghRBC Capital$525.00$471.2311.41%0.11%
Oct 01, 2024Vijay KumarEvercore ISI$475.00$491.27-3.31%-9.43%
Aug 22, 2024Joanne WuenschCitigroup$560.00$487.4214.89%6.78%
Jul 19, 2024Drew RanieriMorgan Stanley$475.00$451.615.18%-9.43%
Jul 19, 2024Vijay KumarEvercore ISI$410.00$416.14-1.48%-21.82%
Jul 19, 2024Rick WiseStifel Nicolaus$475.00$416.1414.14%-9.43%
Jul 19, 2024Richard NewitterTruist Financial$520.00$455.0114.28%-0.84%
Jul 19, 2024Adam MaederPiper Sandler$495.00$416.1418.95%-5.61%
Jul 16, 2024Richard NewitterTruist Financial$515.00$440.6416.87%-1.80%
May 30, 2024David RomanGoldman Sachs$500.00$398.4025.50%-4.66%
Apr 19, 2024Adam MaederPiper Sandler$435.00$368.1718.15%-17.05%
Apr 19, 2024Matthew TaylorJefferies$375.00$372.630.64%-28.49%
Apr 19, 2024David RescottRobert W. Baird$436.00$372.6317.01%-16.86%
Apr 19, 2024Imron ZafarDeutsche Bank$390.00$372.634.66%-25.63%
Apr 19, 2024Ryan ZimmermanBTIG$421.00$372.6312.98%-19.72%
Apr 08, 2024Rick WiseStifel Nicolaus$430.00$388.3910.71%-18.01%
Oct 20, 2023Jayson BedfordRaymond James$310.00$267.0716.07%-40.89%
Oct 20, 2023Shagun SinghRBC Capital$355.00$267.0732.92%-32.31%
Oct 20, 2023Anthony PetroneMizuho Securities$320.00$267.0719.82%-38.98%
Apr 19, 2023Matt MiksicBarclays$314.00$298.575.17%-40.13%
Jan 06, 2023Morgan Stanley$290.00$270.577.18%-44.70%
Dec 22, 2022Argus Research$320.00$262.3721.96%-38.98%
Dec 20, 2022Truist Financial$310.00$258.1720.08%-40.89%
Dec 12, 2022Wells Fargo$305.00$270.9912.55%-41.84%
Dec 05, 2022BTIG$316.00$269.4517.28%-39.74%
Nov 18, 2022J.P. Morgan$280.00$266.385.11%-46.61%
Sep 09, 2022Rick WiseStifel Nicolaus$260.00$214.7821.05%-50.42%
Aug 02, 2022Shagun SinghRBC Capital$285.00$237.7119.89%-45.66%
Jul 22, 2022Truist Financial$255.00$216.6617.69%-51.38%
Jul 22, 2022Rick WiseStifel Nicolaus$250.00$224.7511.23%-52.33%
Jul 18, 2022BTIG$247.00$212.9316.00%-52.90%
Jul 18, 2022Stifel Nicolaus$270.00$212.7926.89%-48.52%
Jul 13, 2022Truist Financial$270.00$202.8033.14%-48.52%
Jun 29, 2022Imron ZafarDeutsche Bank$225.00$202.5911.06%-57.10%
Apr 27, 2022Lawrence KeuschRaymond James$330.00$244.5234.96%-37.07%
Apr 25, 2022Morgan Stanley$300.00$257.2916.60%-42.80%
Apr 22, 2022Wells Fargo$339.00$261.6529.56%-35.36%
Apr 22, 2022Piper Sandler$316.00$294.577.28%-39.74%
Apr 21, 2022Ryan ZimmermanBTIG$355.00$294.5720.51%-32.31%
Apr 18, 2022Vijay KumarEvercore ISI$294.00$276.926.17%-43.94%
Apr 18, 2022Shagun SinghRBC Capital$340.00$276.9222.78%-35.17%
Mar 03, 2022Travis SteedBank of America Securities$340.00$299.8213.40%-35.17%
Jan 21, 2022Jayson BedfordRaymond James$334.00$269.5323.92%-36.31%
Jan 21, 2022Larry BiegelsenWells Fargo$350.00$269.5329.86%-33.26%
Jan 21, 2022Imron ZafarDeutsche Bank$300.00$269.5311.30%-42.80%
Jan 21, 2022Drew RanieriMorgan Stanley$325.00$269.5320.58%-38.03%
Jan 21, 2022Ryan ZimmermanBTIG$360.00$269.5333.57%-31.35%
Jan 21, 2022Joanne WuenschCitigroup$360.00$269.5333.57%-31.35%
Jan 21, 2022Rick WiseStifel Nicolaus$325.00$269.5320.58%-38.03%
Aug 25, 2021Richard NewitterLeerink Partners$346.63$347.99-0.39%-33.90%
Jul 21, 2021JP McKimThrivent$323.30$314.982.64%-38.35%

The latest Intuitive Surgical stock forecast, released on Dec 02, 2024 by Patrick Wood from Morgan Stanley, set a price target of $650.00, which represents a 19.94% increase from the stock price at the time of the forecast ($541.93), and a 23.94% increase from ISRG last price ($524.43).

Intuitive Surgical Price Target by Period

1M3M12M
# Anlaysts11428
Avg Price Target$650.00$540.43$500.11
Last Closing Price$524.43$524.43$524.43
Upside/Downside23.94%3.05%-4.64%

In the current month, the average price target of Intuitive Surgical stock is $650.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 23.94% increase as opposed to Intuitive Surgical's last price of $524.43. This month's average price target is up 20.27% compared to last quarter, and up 29.97% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 18, 2024Piper SandlerOverweightOverweightHold
Oct 18, 2024OppenheimerPerformPerformHold
Oct 18, 2024Evercore ISICautiousCautiousHold
Oct 15, 2024Wells FargoOverweightOverweightHold
Oct 14, 2024Raymond JamesOutperformOutperformHold
Oct 14, 2024BTIGBuyBuyHold
Oct 08, 2024RBC CapitalOutperformOutperformHold
Oct 01, 2024Evercore ISIPositivePositiveHold
Aug 28, 2024BTIGBuyBuyHold
Aug 22, 2024CitigroupBuyBuyHold
Aug 16, 2024RBC CapitalOutperformOutperformHold
Jul 19, 2024William BlairOutperformOutperformHold
Jul 19, 2024Evercore ISIPositivePositiveHold
Jul 19, 2024BTIGBuyBuyHold
Jul 18, 2024BarclaysOverweightOverweightHold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Jul 10, 2024CitigroupBuyBuyHold
Jul 09, 2024Piper SandlerOverweightOverweightHold
Jun 11, 2024BTIGBuyBuyHold
May 30, 2024Goldman SachsBuyInitialise
May 28, 2024Piper SandlerOverweightOverweightHold
May 22, 2024CitigroupBuyBuyHold
Apr 19, 2024JefferiesHoldHoldHold
Apr 19, 2024Piper SandlerOverweightOverweightHold
Apr 19, 2024Deutsche BankHoldHoldHold
Apr 19, 2024BTIGBuyBuyHold
Apr 03, 2024CitigroupBuyBuyHold
Jan 25, 2024Raymond JamesOutperformOutperformHold
Oct 20, 2023William BlairOutperformOutperformHold
Oct 20, 2023RBC CapitalOutperformOutperformHold
Oct 20, 2023Piper SandlerOverweightOverweightHold
Oct 20, 2023Raymond JamesOutperformOutperformHold
Jul 21, 2023Wells FargoOverweightOverweightHold
Jul 21, 2023RBC CapitalOutperformOutperformHold
Jun 05, 2023BTIGBuyBuyHold
Apr 19, 2023BarclaysOverweightOverweightHold
Apr 19, 2023CFRABuyUpgrade
Apr 19, 2023OppenheimerPerformPerformHold
Apr 19, 2023Mizuho SecuritiesNeutralNeutralHold
Apr 19, 2023William BlairOutperformOutperformHold
Apr 19, 2023CitigroupBuyBuyHold
Apr 19, 2023RBC CapitalOverweightOverweightHold
Apr 19, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Apr 19, 2023Wells FargoNeutralNeutralHold
Apr 19, 2023Raymond JamesBuyBuyHold
Apr 19, 2023Keefe, Bruyette & WoodsBuyBuyHold
Mar 23, 2023William BlairOutperformInitialise
Jan 06, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Dec 22, 2022Argus ResearchBuyBuyHold
Dec 12, 2022Wells FargoOverweightOverweightHold
Dec 05, 2022BTIGBuyBuyHold
Aug 02, 2022RBC CapitalOutperformOutperformHold
Jul 18, 2022BTIGBuyBuyHold
Jun 29, 2022Deutsche BankHoldHoldHold
May 17, 2022CitigroupBuyBuyHold
Apr 27, 2022Raymond JamesOutperformOutperformHold
Jan 31, 2022Piper SandlerOverweightUpgrade

Intuitive Surgical's last stock rating was published by Piper Sandler on Oct 18, 2024. The company gave ISRG a "Overweight" rating, the same as its previous rate.

Intuitive Surgical Financial Forecast

Intuitive Surgical Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$1.93B$1.74B$1.76B$1.70B$1.66B$1.56B$1.52B$1.49B$1.55B$1.40B$1.46B$1.29B$1.33B$1.08B$852.10M$1.10B$1.28B$1.13B
Avg Forecast$2.92B$2.75B$2.70B$2.54B$2.57B$2.39B$2.34B$2.20B$2.20B$2.01B$1.97B$1.87B$1.89B$1.77B$1.74B$1.59B$1.52B$1.52B$1.56B$1.43B$1.52B$1.38B$1.27B$1.11B$1.25B$970.98M$671.39M$1.05B$1.23B$1.07B
High Forecast$2.97B$2.80B$2.75B$2.58B$2.61B$2.44B$2.39B$2.23B$2.25B$2.01B$1.97B$1.87B$1.92B$1.80B$1.77B$1.62B$1.60B$1.52B$1.56B$1.43B$1.52B$1.38B$1.27B$1.11B$1.25B$970.98M$671.39M$1.05B$1.23B$1.07B
Low Forecast$2.86B$2.70B$2.65B$2.49B$2.52B$2.35B$2.30B$2.17B$2.16B$2.01B$1.97B$1.87B$1.85B$1.74B$1.71B$1.56B$1.45B$1.52B$1.56B$1.43B$1.52B$1.38B$1.27B$1.11B$1.25B$970.98M$671.39M$1.05B$1.23B$1.07B
# Analysts1075585411171551011559544755107999955
Surprise %------------1.02%0.99%1.01%1.06%1.09%1.02%0.98%1.04%1.02%1.01%1.15%1.16%1.06%1.11%1.27%1.05%1.04%1.06%

Intuitive Surgical's average Quarter revenue forecast for Mar 24 based on 10 analysts is $1.87B, with a low forecast of $1.87B, and a high forecast of $1.87B. ISRG's average Quarter revenue forecast represents a -3.01% decrease compared to the company's last Quarter revenue of $1.93B (Dec 23).

Intuitive Surgical EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585411171551011559544755107999955
EBITDA------------$573.40M$465.80M$463.20M$387.60M$372.50M$398.90M$397.60M$408.10M$533.00M$536.40M$596.00M$511.60M$517.90M$421.50M$168.80M$368.80M$490.50M$448.00M
Avg Forecast$833.20M$785.86M$771.44M$724.52M$732.76M$682.93M$669.20M$627.56M$628.81M$572.51M$562.84M$550.10M$539.03M$505.25M$497.14M$500.09M$577.14M$434.99M$445.49M$454.63M$434.36M$395.23M$361.85M$338.47M$356.61M$277.19M$191.66M$347.02M$351.46M$304.41M
High Forecast$848.64M$800.42M$785.73M$737.94M$746.33M$695.59M$681.60M$636.16M$643.10M$572.52M$562.84M$660.12M$549.02M$514.61M$506.35M$600.11M$692.57M$434.99M$445.49M$545.56M$434.36M$395.23M$361.85M$406.17M$356.61M$277.19M$191.66M$416.42M$351.46M$304.41M
Low Forecast$817.06M$770.63M$756.49M$710.48M$718.56M$669.70M$656.23M$618.97M$617.38M$572.50M$562.84M$440.08M$528.59M$495.46M$487.51M$400.07M$461.71M$434.99M$445.49M$363.70M$434.36M$395.23M$361.85M$270.78M$356.61M$277.19M$191.66M$277.62M$351.46M$304.41M
Surprise %------------1.06%0.92%0.93%0.78%0.65%0.92%0.89%0.90%1.23%1.36%1.65%1.51%1.45%1.52%0.88%1.06%1.40%1.47%

10 analysts predict ISRG's average Quarter EBITDA for Mar 24 to be $550.10M, with a high of $660.12M and a low of $440.08M. This is -4.06% lower than Intuitive Surgical's previous annual EBITDA (Dec 23) of $573.40M.

Intuitive Surgical Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585411171551011559544755107999955
Net Income------------$606.20M$415.70M$420.80M$355.30M$324.90M$324.00M$307.80M$365.60M$382.70M$380.50M$517.20M$426.30M$365.20M$313.90M$68.00M$313.50M$357.70M$396.80M
Avg Forecast$867.71M$849.35M$827.71M$746.15M$751.41M$733.63M$717.05M$643.17M$636.24M$595.60M$559.23M$421.90M$538.23M$513.47M$482.15M$383.54M$412.12M$409.59M$432.19M$348.67M$461.55M$420.77M$369.95M$282.04M$375.99M$247.94M$64.12M$294.99M$406.44M$359.88M
High Forecast$888.62M$869.81M$847.64M$764.12M$769.50M$751.30M$734.33M$664.97M$668.78M$613.87M$559.26M$506.27M$560.20M$518.47M$493.77M$460.25M$494.54M$409.59M$439.88M$418.41M$461.55M$435.16M$372.40M$338.45M$375.99M$247.94M$64.12M$353.98M$406.44M$359.88M
Low Forecast$845.86M$827.96M$806.86M$727.36M$732.48M$715.16M$699.00M$625.00M$603.71M$577.33M$559.20M$337.52M$512.60M$508.47M$470.01M$306.83M$329.69M$409.59M$424.51M$278.94M$461.55M$406.37M$367.50M$225.63M$375.99M$247.94M$64.12M$235.99M$406.44M$359.88M
Surprise %------------1.13%0.81%0.87%0.93%0.79%0.79%0.71%1.05%0.83%0.90%1.40%1.51%0.97%1.27%1.06%1.06%0.88%1.10%

Intuitive Surgical's average Quarter net income forecast for Mar 24 is $421.90M, with a range of $337.52M to $506.27M. ISRG's average Quarter net income forecast represents a -30.40% decrease compared to the company's last Quarter net income of $606.20M (Dec 23).

Intuitive Surgical SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585411171551011559544755107999955
SG&A------------$567.10M$452.00M$464.30M$480.50M$494.30M$436.10M$418.40M$391.10M$427.00M$363.30M$350.20M$326.00M$330.20M$298.90M$279.10M$308.10M$341.80M$284.00M
Avg Forecast$790.56M$745.64M$731.96M$687.44M$695.26M$647.98M$634.95M$595.45M$596.63M$543.21M$534.03M$451.32M$511.44M$479.39M$471.70M$410.29M$462.36M$412.73M$422.69M$372.99M$412.13M$375.00M$343.34M$215.68M$338.37M$263.00M$181.85M$289.91M$333.47M$288.84M
High Forecast$805.21M$759.46M$745.52M$700.18M$708.14M$659.99M$646.72M$603.61M$610.19M$543.22M$534.03M$541.59M$520.92M$488.28M$480.44M$492.35M$554.83M$412.73M$422.69M$447.59M$412.13M$375.00M$343.34M$258.82M$338.37M$263.00M$181.85M$347.89M$333.47M$288.84M
Low Forecast$775.25M$731.19M$717.78M$674.12M$681.79M$635.43M$622.65M$587.29M$585.78M$543.20M$534.03M$361.06M$501.54M$470.11M$462.56M$328.23M$369.89M$412.73M$422.69M$298.39M$412.13M$375.00M$343.34M$172.54M$338.37M$263.00M$181.85M$231.92M$333.47M$288.84M
Surprise %------------1.11%0.94%0.98%1.17%1.07%1.06%0.99%1.05%1.04%0.97%1.02%1.51%0.98%1.14%1.53%1.06%1.02%0.98%

Intuitive Surgical's average Quarter SG&A projection for Mar 24 is $451.32M, based on 10 Wall Street analysts, with a range of $361.06M to $541.59M. The forecast indicates a -20.42% fall compared to ISRG last annual SG&A of $567.10M (Dec 23).

Intuitive Surgical EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1075585411171551011559544755107999955
EPS-------------$1.18$1.20$1.01$0.93$0.91$0.86$1.02$1.07$1.07$1.45$1.20$1.04$0.89$0.19$0.90$1.03$1.15
Avg Forecast$2.39$2.34$2.28$2.06$2.07$2.02$1.98$1.77$1.75$1.64$1.54$1.42$1.48$1.42$1.33$1.20$1.13$1.13$1.20$1.08$1.28$1.17$1.02$0.88$1.04$0.69$0.18$0.88$1.13$1.00
High Forecast$2.45$2.40$2.34$2.11$2.12$2.07$2.02$1.83$1.84$1.69$1.54$1.42$1.54$1.43$1.36$1.23$1.19$1.13$1.22$1.08$1.28$1.21$1.03$0.88$1.04$0.69$0.18$0.88$1.13$1.00
Low Forecast$2.33$2.28$2.22$2.01$2.02$1.97$1.93$1.72$1.66$1.59$1.54$1.42$1.41$1.40$1.30$1.17$1.08$1.13$1.18$1.08$1.28$1.13$1.02$0.88$1.04$0.69$0.18$0.88$1.13$1.00
Surprise %-------------0.83%0.90%0.84%0.82%0.80%0.72%0.95%0.84%0.92%1.42%1.36%1.00%1.30%1.09%1.02%0.91%1.15%

According to 11 Wall Street analysts, Intuitive Surgical's projected average Quarter EPS for Dec 23 is $1.48, with a low estimate of $1.41 and a high estimate of $1.54. This represents a 25.76% increase compared to ISRG previous annual EPS of $1.18 (Sep 23).

Intuitive Surgical Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
BNGOBionano Genomics$0.21$1.00376.19%Buy
TFXTeleflex$178.28$254.5042.75%Buy
BAXBaxter$29.64$39.0031.58%Hold
BDXBecton, Dickinson and Company$225.64$278.7523.54%Buy
RGENRepligen$158.14$193.4022.30%Buy
COOCooper Companies$94.49$115.0021.71%Buy
ICUIICU Medical$157.17$190.5021.21%Buy
WSTWest Pharmaceutical Services$334.26$393.0017.57%Buy
EMBCEmbecta$19.82$23.0016.04%Buy
MMSIMerit Medical Systems$99.00$108.839.93%Buy
HOLXHologic$72.26$74.202.68%Buy
ISRGIntuitive Surgical$545.16$550.671.01%Buy
RMDResMed$242.62$233.50-3.76%Hold

ISRG Forecast FAQ

Is Intuitive Surgical a good buy?

Yes, according to 16 Wall Street analysts, Intuitive Surgical (ISRG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 12 'Buy' recommendations, accounting for 75.00% of ISRG's total ratings.

What is ISRG's price target?

Intuitive Surgical (ISRG) average price target is $550.67 with a range of $466 to $650, implying a 5.00% from its last price of $524.43. The data is based on 16 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Intuitive Surgical stock go up soon?

According to Wall Street analysts' prediction for ISRG stock, the company can go up by 5.00% (from the last price of $524.43 to the average price target of $550.67), up by 23.94% based on the highest stock price target, and down by -11.14% based on the lowest stock price target.

Can Intuitive Surgical stock reach $800?

ISRG's average twelve months analyst stock price target of $550.67 does not support the claim that Intuitive Surgical can reach $800 in the near future.

What is Intuitive Surgical's current price target trend?

1 Wall Street analyst forecast a $650 price target for Intuitive Surgical (ISRG) this month, up 23.94% from its last price of $524.43. Compared to the last 3 and 12 months, the average price target increased by 3.05% and decreased by -4.64%, respectively.

What are Intuitive Surgical's analysts' financial forecasts?

Intuitive Surgical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $9.5B (high $9.67B, low $9.33B), average EBITDA is $2.71B (high $2.76B, low $2.66B), average net income is $2.85B (high $2.92B, low $2.77B), average SG&A $2.57B (high $2.62B, low $2.53B), and average EPS is $7.84 (high $8.05, low $7.64). ISRG's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $10.91B (high $11.11B, low $10.7B), average EBITDA is $3.12B (high $3.17B, low $3.05B), average net income is $3.29B (high $3.37B, low $3.21B), average SG&A $2.96B (high $3.01B, low $2.9B), and average EPS is $9.07 (high $9.29, low $8.84).

Did the ISRG's actual financial results beat the analysts' financial forecasts?

Based on Intuitive Surgical's last annual report (Dec 2023), the company's revenue was $7.12B, beating the average analysts forecast of $6.99B by 1.88%. Apple's EBITDA was $2.19B, beating the average prediction of $2.04B by 7.20%. The company's net income was $1.8B, missing the average estimation of $1.92B by -6.23%. Apple's SG&A was $1.96B, beating the average forecast of $1.87B by 4.86%. Lastly, the company's EPS was $5.12, missing the average prediction of $5.43 by -5.63%. In terms of the last quarterly report (Dec 2023), Intuitive Surgical's revenue was $1.93B, beating the average analysts' forecast of $1.89B by 2.12%. The company's EBITDA was $573.4M, beating the average prediction of $539.03M by 6.38%. Intuitive Surgical's net income was $606.2M, beating the average estimation of $538.23M by 12.63%. The company's SG&A was $567.1M, beating the average forecast of $511.44M by 10.88%. Lastly, the company's EPS was $0, missing the average prediction of $1.48 by -100.00%